Bramble Venture Partners Limited


Directors	Henry Dimbleby
	Omar El-Habbal
	Mark Hudson
	Archibald Mason
	Christopher Mitchell


Registered Address	1 Warwick Street
	London
	W1B 5LR


Registered Number	15329566 (England and Wales)

Statement of Financial Position
31 December 2024

	Notes	2024
		£	£
Called up share capital not paid			26
Current assets
Debtors	3	26,000
Cash at bank and on hand		60,687
		86,687
Creditors amounts falling due within one year	4	(241,820)
Net current assets (liabilities)			(155,107)
Total assets less current liabilities			(155,107)
Accruals and deferred income			(46,251)
Net assets			(201,358)
Capital and reserves
Called up share capital			100
Profit and loss account			(201,458)
Shareholders' funds			(201,358)

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 19 November 2025, and are signed on its behalf by:

Archibald Mason
Director
Registered Company No. 15329566

Bramble Venture Partners Limited

Notes to the Financial Statements
for the period ended 31 December 2024

1.	Accounting policies

	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

	Statement of compliance
	The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Going concern
	At the balance sheet date, the company had net liabilities of £201,458. These financial statements have been prepared on a going concern basis on the assumption that the directors and shareholders will continue to provide financial support to the company as required. The directors have not identified any material uncertainties that may cast significant doubt on the company’s ability to continue as a going concern. In forming this view, the directors have considered all relevant information, including recent capital injections, cash flow forecasts and known post balance sheet events. Based on this assessment, the directors have a reasonable expectation that the company has sufficient resources to continue operating for at least twelve months from the date of approval of the financial statements.

Going concern

At the balance sheet date, the company had net liabilities of £201,458. These financial statements have been prepared on a going concern basis on the assumption that the directors and shareholders will continue to provide financial support to the company as required.

The directors have not identified any material uncertainties that may cast significant doubt on the company’s ability to continue as a going concern.
 
In forming this view, the directors have considered all relevant information, including recent capital injections, cash flow forecasts and known post balance sheet events. Based on this assessment, the directors have a reasonable expectation that the company has sufficient resources to continue operating for at least twelve months from the date of approval of the financial statements.

	Cash and cash equivalents
	Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.

Cash and cash equivalents

Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less.

Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.

	Trade and other creditors
	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

	Financial instruments
	A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.

Financial instruments

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment.

Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. 

2.	Average number of employees


		2024
	Average number of employees during the year	0

3.	Debtors: amounts due within one year

		2024
		£
	Other debtors	26,000
	Total	26,000

4.	Creditors: amounts due within one year

		2024
		£
	Trade creditors / trade payables	2,063
	Taxation and social security	4,757
	Other creditors	235,000
	Total	241,820

5.	Controlling party
	No single individual or entity has the ability to exercise overall control of the company. The directors therefore consider that control is collectively exercised by the shareholders and that there is no ultimate controlling party.